Black Rock Inc. Nutri Band Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Nutri Band Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,048 shares of NTRB stock, worth $4,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,048

Holding current value

$4,275

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.35 - $6.16 $3,510 - $6,455	1,048 New	1,048 $5,000
Q1 2023 May 12, 2023	BUY	$2.9 - $4.96 $1,113 - $1,904	384 Added 3.32%	11,934 $39,000
Q4 2022 Feb 13, 2023	SELL	$3.53 - $4.5 $8,779 - $11,191	-2,487 Reduced 17.72%	11,550 $41,000
Q3 2022 Nov 14, 2022	SELL	$3.49 - $7.83 $3,877 - $8,699	-1,111 Reduced 7.33%	14,037 $50,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $5.69 $33,113 - $67,050	11,784 Added 350.3%	15,148 $62,000
Q1 2022 May 12, 2022	BUY	$3.3 - $9.43 $231 - $660	70 Added 2.13%	3,364 $14,000
Q4 2021 Feb 10, 2022	BUY	$3.14 - $10.08 $10,343 - $33,203	3,294 New	3,294 $33,000

Others Institutions Holding NTRB

# of Institutions

Shares Held

284K

Call Options Held

Put Options Held

View Full List

About NutriBand Inc.

Ticker NTRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,803,260
Market Cap $31.8M
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...

More about NTRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account